IBDEI03T ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4700,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,4700,1,5,0)
 ;;=5^CLL In Remission
 ;;^UTILITY(U,$J,358.3,4700,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,4701,0)
 ;;=201.90^^28^256^74
 ;;^UTILITY(U,$J,358.3,4701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4701,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,4701,1,5,0)
 ;;=5^Hodgkin's Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,4701,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,4702,0)
 ;;=785.6^^28^256^80
 ;;^UTILITY(U,$J,358.3,4702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4702,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,4702,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,4702,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,4703,0)
 ;;=200.20^^28^256^81
 ;;^UTILITY(U,$J,358.3,4703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4703,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,4703,1,5,0)
 ;;=5^Lymphoma, Burkitt's, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,4703,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,4704,0)
 ;;=202.00^^28^256^83
 ;;^UTILITY(U,$J,358.3,4704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4704,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,4704,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,4704,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,4705,0)
 ;;=200.10^^28^256^82
 ;;^UTILITY(U,$J,358.3,4705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4705,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,4705,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,4705,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,4706,0)
 ;;=273.3^^28^256^84
 ;;^UTILITY(U,$J,358.3,4706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4706,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,4706,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,4706,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,4707,0)
 ;;=203.00^^28^256^96
 ;;^UTILITY(U,$J,358.3,4707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4707,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,4707,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,4707,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,4708,0)
 ;;=203.01^^28^256^95
 ;;^UTILITY(U,$J,358.3,4708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4708,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,4708,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,4708,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,4709,0)
 ;;=238.6^^28^256^99
 ;;^UTILITY(U,$J,358.3,4709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4709,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,4709,1,5,0)
 ;;=5^Plasmacytoma NOS
 ;;^UTILITY(U,$J,358.3,4709,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,4710,0)
 ;;=205.00^^28^256^4
 ;;^UTILITY(U,$J,358.3,4710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4710,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,4710,1,5,0)
 ;;=5^AML w/o Remission
 ;;^UTILITY(U,$J,358.3,4710,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,4711,0)
 ;;=205.01^^28^256^3
 ;;^UTILITY(U,$J,358.3,4711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4711,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,4711,1,5,0)
 ;;=5^AML In Remission
 ;;^UTILITY(U,$J,358.3,4711,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,4712,0)
 ;;=205.10^^28^256^15
 ;;^UTILITY(U,$J,358.3,4712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4712,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,4712,1,5,0)
 ;;=5^CML w/o Remission
 ;;^UTILITY(U,$J,358.3,4712,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,4713,0)
 ;;=205.11^^28^256^14
 ;;^UTILITY(U,$J,358.3,4713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4713,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,4713,1,5,0)
 ;;=5^CML In Remission
 ;;^UTILITY(U,$J,358.3,4713,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,4714,0)
 ;;=289.0^^28^256^48
 ;;^UTILITY(U,$J,358.3,4714,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4714,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,4714,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,4714,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,4715,0)
 ;;=238.4^^28^256^100
 ;;^UTILITY(U,$J,358.3,4715,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4715,1,4,0)
 ;;=4^238.4
 ;;^UTILITY(U,$J,358.3,4715,1,5,0)
 ;;=5^Polycytheria Rubra Vera
 ;;^UTILITY(U,$J,358.3,4715,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,4716,0)
 ;;=V58.61^^28^256^113
 ;;^UTILITY(U,$J,358.3,4716,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4716,1,4,0)
 ;;=4^V58.61
 ;;^UTILITY(U,$J,358.3,4716,1,5,0)
 ;;=5^Warfarin/Coumadin Use
 ;;^UTILITY(U,$J,358.3,4716,2)
 ;;=Warfarin/Coumadin Use^303459
 ;;^UTILITY(U,$J,358.3,4717,0)
 ;;=282.49^^28^256^105
 ;;^UTILITY(U,$J,358.3,4717,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4717,1,4,0)
 ;;=4^282.49
 ;;^UTILITY(U,$J,358.3,4717,1,5,0)
 ;;=5^Thalassemia NEC
 ;;^UTILITY(U,$J,358.3,4717,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,4718,0)
 ;;=289.89^^28^256^11
 ;;^UTILITY(U,$J,358.3,4718,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4718,1,4,0)
 ;;=4^289.89
 ;;^UTILITY(U,$J,358.3,4718,1,5,0)
 ;;=5^Blood Diseases NEC
 ;;^UTILITY(U,$J,358.3,4718,2)
 ;;=^329887
 ;;^UTILITY(U,$J,358.3,4719,0)
 ;;=238.79^^28^256^79
 ;;^UTILITY(U,$J,358.3,4719,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4719,1,4,0)
 ;;=4^238.79
 ;;^UTILITY(U,$J,358.3,4719,1,5,0)
 ;;=5^Lymph/Hematpoitc Tis NEC
 ;;^UTILITY(U,$J,358.3,4719,2)
 ;;=^334033
 ;;^UTILITY(U,$J,358.3,4720,0)
 ;;=287.30^^28^256^101
 ;;^UTILITY(U,$J,358.3,4720,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4720,1,4,0)
 ;;=4^287.30
 ;;^UTILITY(U,$J,358.3,4720,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,4720,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,4721,0)
 ;;=288.09^^28^256^5
 ;;^UTILITY(U,$J,358.3,4721,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4721,1,4,0)
 ;;=4^288.09
 ;;^UTILITY(U,$J,358.3,4721,1,5,0)
 ;;=5^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,4721,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,4722,0)
 ;;=V10.21^^28^256^54
 ;;^UTILITY(U,$J,358.3,4722,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4722,1,4,0)
 ;;=4^V10.21
 ;;^UTILITY(U,$J,358.3,4722,1,5,0)
 ;;=5^H/O Laryngeal Cancer
 ;;^UTILITY(U,$J,358.3,4722,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,4723,0)
 ;;=284.2^^28^256^97
 ;;^UTILITY(U,$J,358.3,4723,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4723,1,4,0)
 ;;=4^284.2
 ;;^UTILITY(U,$J,358.3,4723,1,5,0)
 ;;=5^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,4723,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,4724,0)
 ;;=202.40^^28^256^67
 ;;^UTILITY(U,$J,358.3,4724,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4724,1,4,0)
 ;;=4^202.40
 ;;^UTILITY(U,$J,358.3,4724,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspecified site
 ;;^UTILITY(U,$J,358.3,4724,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,4725,0)
 ;;=287.49^^28^256^106
 ;;^UTILITY(U,$J,358.3,4725,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4725,1,4,0)
 ;;=4^287.49
 ;;^UTILITY(U,$J,358.3,4725,1,5,0)
 ;;=5^Thrombocytopenia,Drug Induced
 ;;^UTILITY(U,$J,358.3,4725,2)
 ;;=^339610
 ;;^UTILITY(U,$J,358.3,4726,0)
 ;;=285.9^^28^256^9
 ;;^UTILITY(U,$J,358.3,4726,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4726,1,4,0)
 ;;=4^285.9
 ;;^UTILITY(U,$J,358.3,4726,1,5,0)
 ;;=5^Anemia NOS
 ;;^UTILITY(U,$J,358.3,4726,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,4727,0)
 ;;=465.9^^28^257^64
 ;;^UTILITY(U,$J,358.3,4727,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4727,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,4727,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,4727,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,4728,0)
 ;;=599.0^^28^257^65
 ;;^UTILITY(U,$J,358.3,4728,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4728,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,4728,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,4728,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,4729,0)
 ;;=460.^^28^257^42
 ;;^UTILITY(U,$J,358.3,4729,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4729,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,4729,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,4729,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,4730,0)
 ;;=562.11^^28^257^9
 ;;^UTILITY(U,$J,358.3,4730,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4730,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,4730,1,5,0)
 ;;=5^Diverticulitis
 ;;^UTILITY(U,$J,358.3,4730,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,4731,0)
 ;;=424.90^^28^257^10
 ;;^UTILITY(U,$J,358.3,4731,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4731,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,4731,1,5,0)
 ;;=5^Endocarditis
 ;;^UTILITY(U,$J,358.3,4731,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,4732,0)
 ;;=558.9^^28^257^17
 ;;^UTILITY(U,$J,358.3,4732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4732,1,4,0)
 ;;=4^558.9
 ;;^UTILITY(U,$J,358.3,4732,1,5,0)
 ;;=5^Gastroenteritis
 ;;^UTILITY(U,$J,358.3,4732,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,4733,0)
 ;;=054.71^^28^257^30
 ;;^UTILITY(U,$J,358.3,4733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4733,1,4,0)
 ;;=4^054.71
 ;;^UTILITY(U,$J,358.3,4733,1,5,0)
 ;;=5^Herpes Simplex,Visceral
 ;;^UTILITY(U,$J,358.3,4733,2)
 ;;=^266574
 ;;^UTILITY(U,$J,358.3,4734,0)
 ;;=054.10^^28^257^18
 ;;^UTILITY(U,$J,358.3,4734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4734,1,4,0)
 ;;=4^054.10
 ;;^UTILITY(U,$J,358.3,4734,1,5,0)
 ;;=5^Genital Herpes, Unsp
 ;;^UTILITY(U,$J,358.3,4734,2)
 ;;=^56853
 ;;^UTILITY(U,$J,358.3,4735,0)
 ;;=054.13^^28^257^32
 ;;^UTILITY(U,$J,358.3,4735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4735,1,4,0)
 ;;=4^054.13
 ;;^UTILITY(U,$J,358.3,4735,1,5,0)
 ;;=5^Herpetic Infect Of Penis
 ;;^UTILITY(U,$J,358.3,4735,2)
 ;;=^266560
 ;;^UTILITY(U,$J,358.3,4736,0)
 ;;=054.11^^28^257^33
 ;;^UTILITY(U,$J,358.3,4736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4736,1,4,0)
 ;;=4^054.11
 ;;^UTILITY(U,$J,358.3,4736,1,5,0)
 ;;=5^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,4736,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,4737,0)
 ;;=053.9^^28^257^31
 ;;^UTILITY(U,$J,358.3,4737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4737,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,4737,1,5,0)
 ;;=5^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,4737,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,4738,0)
 ;;=487.1^^28^257^34
 ;;^UTILITY(U,$J,358.3,4738,1,0)
 ;;=^358.31IA^5^2
